Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Journal of Radiation Research|October 30, 2007
A novel role for thyroid hormone receptor beta in cellular radiosensitivityMichiko Matsuse, Vladimir Saenko, Ilya Sedliarou, et al.
Scientific Reports|February 3, 2017
TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factorsMichiko Matsuse, Tomonori Yabuta, Vladimir Saenko, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2013
Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the diseaseIñigo Landa, Ian Ganly, Timothy A Chan, et al.
The Journal of Investigative Dermatology|February 24, 2012
miR-196a downregulation increases the expression of type I and III collagens in keloid fibroblastsKazuya Kashiyama, Norisato Mitsutake, Michiko Matsuse, et al.
Frontiers in Pediatrics|November 21, 2022
Aicardi-Goutières syndrome with SAMHD1 deficiency can be diagnosed by unscheduled DNA synthesis testChikako Senju, Yuka Nakazawa, Mayuko Shimada, et al.
Scientific Reports|November 21, 2015
BRAF(V600E) mutation is highly prevalent in thyroid carcinomas in the young population in Fukushima: a different oncogenic profile from ChernobylNorisato Mitsutake, Toshihiko Fukushima, Michiko Matsuse, et al.
Free Radical Research|November 26, 2008
Dehydroepiandrosterone augments sensitivity to gamma-ray irradiation in human H4 neuroglioma cells through down-regulation of Akt signalingTomohito Hirao, Yoshishige Urata, Kan Kageyama, et al.
Cancer Letters|May 7, 2010
miR-195, miR-455-3p and miR-10a( *) are implicated in acquired temozolomide resistance in glioblastoma multiforme cellsKenta Ujifuku, Norisato Mitsutake, Shu Takakura, et al.
Plos One|May 11, 2011
Dedifferentiation of human primary thyrocytes into multilineage progenitor cells without gene introductionKeiji Suzuki, Norisato Mitsutake, Vladimir Saenko, et al.
Endocrinology|July 26, 2008
Dehydroxymethylepoxyquinomicin, a novel nuclear Factor-kappaB inhibitor, enhances antitumor activity of taxanes in anaplastic thyroid cancer cellsZhaowei Meng, Norisato Mitsutake, Masahiro Nakashima, et al.
Pageof 5